Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHarvey Nash Group Regulatory News (HVN)

  • There is currently no data for HVN

Interim Management Statement

31 May 2013 07:00

RNS Number : 9780F
Harvey Nash Group PLC
31 May 2013
 



HARVEY NASH GROUP PLC

('Harvey Nash' or 'the Group')

 

Interim Management Statement

 

Harvey Nash, the global professional services group, today issues an Interim Management Statement covering the period from 1st February 2013 to 30th May 2013. There have been no material events or transactions in the period other than those detailed in this statement. The Group's financial year ends on 31st January 2014.

 

Current Trading 

 

There has been no change in the Group's trading since the full year preliminary results announcement on 30 April 2013.

 

As expected, and stated in the preliminary announcement, the Group experienced a slower start to the first quarter of the current year as a result of the general caution in the market, weakness in Europe and the impact of seasonality on our Vietnamese and Hong Kong businesses. Notwithstanding this, the Board remains confident that the Group is on track to achieve its expectations for the full year.

 

Revenues were 12% ahead of the comparative period in the prior year and gross profit was 7% ahead. However, owing to the timing of Chinese New Year falling in February 2013 and the impact of client delays to projects in our German outsourcing business, operating profit was 14% below the previous year. As previously reported, actions have been implemented to align costs with revenues in that business. Elsewhere in the UK and Europe, temporary recruitment remains robust, and a slight pick-up in executive recruitment has been reported. The US market has picked up and towards the end of the quarter there were encouraging signs of gradually increasing trading momentum across the board, with the result that April's operating profit was ahead of the same period in the previous year.

 

Dividend

 

As set out in the preliminary statement announcement on 30th April, the Board intends to recommend an increased final dividend of 1.795 pence per share, 10% up on the prior year (2012: 1.635p). If approved at the forthcoming Annual General Meeting the final dividend, which would take total dividend payouts for the year to 2.92 pence per share (2012: 2.66p), will be paid on 12 July 2013 to shareholders on the register as at 21st June 2013. This marks the sixth successive annual increase. 

 

Acquisition

As announced on 30th April 2013, the Company has exercised its option to acquire the remaining 49.9% of the issued share capital of Bjerke & Luther AS in Norway for an aggregate consideration of NOK 11.5 million (approximately £1.3 million), settled in cash and funded from the Company's existing cash resources and facilities.

Financial position

 

The Group maintains substantial headroom in its banking facilities. Increased facilities to fund future growth were secured in February bringing the total to c£52m.

 

Summary

 

We remain encouraged by the exit run rates of the first quarter confirming an improving trend into the second quarter and, despite continued challenging trading conditions in Europe, the Board is confident that the Group is on track to achieve its expectations for the full year.

 

31st May 2013

 

 

ENQUIRIES:

 

Harvey Nash

Tel: 020 7333 2635

Albert Ellis, Chief Executive Officer

Richard Ashcroft, Group Finance Director

College Hill

Tel: 020 7457 2020

Mark Garraway, Helen Tarbet

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEFLBXXEFZBBB
Date   Source Headline
8th Aug 20184:00 pmRNSForm 8.3 - Harvey Nash Group PLC
8th Aug 201811:43 amPRNForm 8.3 - Harvey Nash Group Plc
8th Aug 20188:54 amPRNForm 8.3 - Harvey Nash Group PLC
7th Aug 20183:14 pmRNSForm 8.3 - [Harvey Nash Group plc]
7th Aug 20183:13 pmPRNForm 8.3 - Harvey Nash Group PLC
7th Aug 20181:40 pmRNSForm 8.3 - Harvey Nash Group plc
7th Aug 20187:10 amRNSRecommended Cash Offer
7th Aug 20187:00 amRNSOffer for Harvey Nash Group plc
1st Aug 201812:42 pmRNSDirector/PDMR Shareholding
1st Aug 20187:00 amRNSTotal Voting Rights
3rd Jul 201810:27 amRNSDirector/PDMR Shareholding
2nd Jul 20187:00 amRNSTotal Voting Rights
28th Jun 20183:00 pmRNSResult of AGM
19th Jun 20184:40 pmRNSHolding(s) in Company
18th Jun 20187:00 amRNSNotice of AGM
12th Jun 20187:00 amRNSBlock listing Interim Review
6th Jun 20187:00 amRNSHarvey Nash/KPMG CIO Survey
6th Jun 20187:00 amRNSTrading Update
1st Jun 20182:14 pmRNSDirector/PDMR Shareholding
1st Jun 20187:00 amRNSTotal Voting Rights
15th May 20187:00 amRNSAcquisition of eMenka NV
1st May 20185:37 pmRNSNotification of Transaction by Directors
1st May 20187:00 amRNSTotal Voting Rights
30th Apr 201812:00 pmRNSCapital Markets Day
30th Apr 20188:54 amRNSDirector/PDMR Shareholding
27th Apr 20187:00 amRNSPRELIMINARY RESULTS
4th Apr 20181:20 pmRNSDirector/PDMR Shareholding
3rd Apr 20187:00 amRNSTotal Voting Rights
2nd Mar 20183:41 pmRNSDirector/PDMR Shareholding
2nd Mar 20187:00 amRNSPre-close Trading Update
1st Mar 20187:00 amRNSTotal Voting Rights
1st Feb 20187:00 amRNSTotal Voting Rights
31st Jan 20184:55 pmRNSDirector/PDMR Shareholding
2nd Jan 20187:00 amRNSTotal Voting Rights
21st Dec 20173:00 pmRNSDirector/PDMR Shareholding
12th Dec 20177:00 amRNSBlock listing Interim Review
1st Dec 20177:00 amRNSTotal Voting Rights
30th Nov 20175:13 pmRNSDirector/PDMR Shareholding
1st Nov 20173:50 pmRNSDirector/PDMR Shareholding
1st Nov 20177:00 amRNSTotal Voting Rights
2nd Oct 20177:00 amRNSTotal Voting Rights
29th Sep 20174:52 pmRNSDirector/PDMR Shareholding
29th Sep 20174:33 pmRNSGrant of Share Awards to Directors
28th Sep 20177:02 amRNSAppointment of non-executive director
28th Sep 20177:00 amRNSUnaudited Interim Results
21st Sep 201712:21 pmRNSHolding(s) in Company
12th Sep 20177:00 amRNSAcquisition of Crimson Limited
1st Sep 201711:10 amRNSDirector/PDMR Shareholding
1st Sep 20177:00 amRNSTotal Voting Rights
25th Aug 20171:27 pmRNSNotice of Half Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.